Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Development and Assessment of Conventional and Targeted Drug Combinations for Use in the Treatment of Aggressive Breast Cancers

Volume:6   Issue: 6
Pp: 455-489
D. N. Waterhouse, K. A. Gelmon, R. Klasa, K. Chi, D. Huntsman, E. Ramsay, E. Wasan, L. Edwards, C. Tucker, J. Zastre, Y. Z. Zhang, D. Yapp, W. Dragowska, S. Dedha and M. B. Bally
DOI: 10.2174/156800906778194586

Synthetic Glycopeptides from the Mucin Family as Potential Tools in Cancer Immunotherapy

Volume:6   Issue: 6
Pp: 491-517
Torsten Becker, Sebastian Dziadek, Sven Wittrock and Horst Kunz
DOI: 10.2174/156800906778194577

Protein Tyrosine Phosphatases, New Targets for Cancer Therapy

Volume:6   Issue: 6
Pp: 519-532
David Easty, William Gallagher and D. C. Bennett
DOI: 10.2174/156800906778194603

Knowledge of Epigenetic Influence for Prostate Cancer Therapy

Volume:6   Issue: 6
Pp: 533-551
Masatoshi Watanabe, Akimitsu Takagi, Takeshi Matsuzaki, Daisuke Kami, Minoru Toyota, Yoshifumi Hirokawa and Taizo Shiraishi
DOI: 10.2174/156800906778194568